Newsfeeds Archive - Page 2 of 3

1 minute read

Why Is Cancer Focused Intensity Therapeutics Stock Trading Over 100% Today?

December 8, 11:22 AM

Intensity Therapeutics Inc (NASDAQ: INTS) announced that safety, tolerability, efficacy, and immune activation data from its Phase 2 INVINCIBLE trial of INT230-6 in patients with early-stage breast cancer without chemotherapy was presented during the 2023 San Antonio

INTS

3 minute read

US Stocks Down; Nonfarm Payrolls Rise By 199,000 In November

By Avi Kapoor

December 8, 10:44 AM

U.S. stocks traded mostly lower this morning, following the release of jobs data on Friday. Following the market opening Friday, the Dow traded down 0.08% to 36,089.67 while the NASDAQ fell 0.24% to 14,306.13. The S&P 500 also fell, dropping, 0.12% to 4,580.07.

AUVI

3 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

November 15, 1:31 PM

Gainers Heron Therapeutics (NASDAQ:HRTX) stock moved upwards by 63.0% to $0.88 during Wednesday’s regular session. As of 12:31…

AYTU

12 minute read

Earnings

Earnings Scheduled For August 14, 2023

By Benzinga Insights

August 14, 6:45 AM

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.

AAMC

5 minute read

Portage Biotech Reports Fiscal Year-Ended March 31, 2023 Financial Results And Business Update; FY23 EPS $(6.49) Vs $(1.29) YoY

By Happy Mohamed

July 31, 4:49 PM

Company poised to accelerate accrual in all clinical programs as it activates numerous sites across multiple U.S. cities and abroad and takes over sponsorship from the investigator-led program Updated interim

INTS

5 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 12:17 PM

During Thursday, 56 stocks hit new 52-week lows.

ABVC

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Yesterday, 5:32 PM

Gainers Lixte Biotech Hldgs (NASDAQ:LIXT) stock increased by 13.5% to $4.45 during Wednesday’s after-market session. The market value…

ACGN

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s After-Market Session

By Benzinga Insights

July 20, 5:32 PM

Gainers Evelo Biosciences (NASDAQ:EVLO) stock increased by 11.7% to $11.01 during Thursday’s after-market session. Trading volume for this…

APVO

16 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For July 18, 2023

By Benzinga Insights

July 18, 11:00 AM

Upgrades For Carnival Corp (NYSE:CCL), Argus Research upgraded the previous rating of Hold to Buy. For the second…

AIRC

1 minute read

Intensity Therapeutics, Inc. IPO Indicating $5.10/Share; IPO Priced At $5/Share On 3.9M Shares

By Happy Mohamed

June 30, 10:53 AM

Intensity Therapeutics, Inc. ("Intensity" or the "Company") (NASDAQ:INTS), a clinical-stage biotechnology company focused on the discovery and development of proprietary, novel immune-based

INTS